Skip to main content

Peer Review reports

From: Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction

Original Submission
13 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Feb 2022 Reviewed Reviewer Report
22 Mar 2022 Reviewed Reviewer Report - Masatake Kobayashi
19 Jul 2022 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 3
19 Jul 2022 Submitted Manuscript version 3
20 Jul 2022 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 4
20 Jul 2022 Submitted Manuscript version 4
27 Jul 2022 Reviewed Reviewer Report
5 Aug 2022 Reviewed Reviewer Report - Masatake Kobayashi
2 Oct 2022 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 5
2 Oct 2022 Submitted Manuscript version 5
15 Mar 2023 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 6
15 Mar 2023 Submitted Manuscript version 6
16 Mar 2023 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 7
16 Mar 2023 Submitted Manuscript version 7
25 Jun 2023 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 8
25 Jun 2023 Submitted Manuscript version 8
28 Jun 2023 Author responded Author comments - Giuseppe Vergaro
Resubmission - Version 9
28 Jun 2023 Submitted Manuscript version 9
Publishing
9 Aug 2023 Editorially accepted
1 Sep 2023 Article published 10.1186/s12872-023-03441-2

You can find further information about peer review here.

Back to article page